Abstract
An estimated 1.6 million soft-tissue filler procedures were performed in 2019, a 78% increase from 2012. As usage of fillers increases, there is increasing concern of associated adverse events. We analyzed the U.S. Food and Drug Administration’s Manufacturer and User Facility Device Experience (MAUDE) database to determine number of dermal filler-related reports, review report details, and compare changes in complications. MAUDE database was filtered for adverse events involving dermal fillers from January 2014 to December 2020.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
